Biotechnology cancer Cell Therapy Clinical Trials Vaccines Experiments in Mice And Human Cells Shed Light On Best Way to Deliver Nanoparticle Therapy For Cancer By Staff Reports 7 months ago Researchers in the cancer nanomedicine community debate whether use of tiny structures, called nanoparticles, can
Cell Therapy Placental-based Treatment Improved Mobility in Patients affected by Intermittent Claudication By Staff Reports 2 years ago Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, announced positive top-line results
Cancer Discovery CAR-T cell therapy has the potential to treat brain tumors By Staff Reports 3 years ago New research shows that an immunotherapy called CAR-T cell therapy – currently only effective in
cancer Placental Cells Significantly Inhibit Cancer Cell Growth in Newly Published Study By Staff Reports 3 years ago According to the peer-reviewed article in the journal Scientific Reports, placenta-derived cells called PLX cells, exhibit
Biotechnology Cell Therapy Clinical Trials stem cells UCLA Researchers Create Skeletal Muscle From Stem Cells By Staff Reports 3 years ago Discovery is major step towards a stem cell replacement therapy for Duchenne Muscular Dystrophy UCLA
Uncategorized US FDA IND Allows for the Initiation of a US Clinical Trial of Novel Cell Pouch for the Treatment of Type 1 Diabetes backed by JDRF By Staff Reports 3 years ago Sernova Corp, a clinical stage company developing regenerative medicine technologies for the long-term treatment of
Diabetes Towards a safe and scalable cell therapy for type 1 diabetes by simplifying beta cell differentiation By Staff Reports 3 years ago More than 36 million people globally are affected by type 1 diabetes (T1D), a lifelong
Biotechnology cancer Cell Therapy T-cells lacking HDAC11 enzyme perform more effectively in destroying cancer cells By Staff Reports 3 years ago Researchers at the George Washington University (GW) Cancer Center have discovered a new role for
cancer Pioneering cancer gene therapy by Novartis backed by U.S. panel By Staff Reports 3 years ago (Reuters) – Novartis AG’s (NOVN.S) pioneering cancer drug won the backing of a federal advisory
Biotechnology Cell Therapy rare diseases Cardiac stem cells from heart disease patients may be harmful By Staff Reports 3 years ago Patients with severe and end-stage heart failure have few treatment options available to them apart
Biotechnology Uncategorized Tissue Engineering Advance Reduces Heart Failure in Model of Heart Attack By Staff Reports 4 years ago Researchers have grown heart tissue by seeding a mix of human cells onto a 1-micron-resolution
cancer Cell Therapy TapImmune’s T-Cell Cancer Vaccine for Worldwide Eradication of Women’s Cancers By Staff Reports 4 years ago Early proof of efficacy, scalability with cost effective manufacturing, and testability in large Phase III
Biotechnology Cell Therapy New stem cell delivery approach regenerates dental pulp-like tissue in a rodent model By Staff Reports 4 years ago When a tooth is damaged, either by severe decay or trauma, the living tissues that
Biotechnology Athersys Receives FDA Agreement Under Special Protocol Assessment for Phase 3 Study of Multistem® Treatment for Ischemic Stroke By Staff Reports 4 years ago Athersys, Inc. announced that it has received agreement from the U.S. Food and Drug Administration
Cell Therapy Clinical Trials Pharmaceutical Business News Athersys Gets Nod from PMDA in Japan to Start Trial for the Treatment of Ischemic Stroke with MultiStem® By Staff Reports 4 years ago Athersys, Inc. got a major nod from Japan’s Pharmaceutical and Medical Devices Agency (PMDA) review
Cell Therapy Pharmaceutical Business News Novartis Dissolves Its Cell Therapy Unit; 120 Positions Eliminated By Staff Reports 4 years ago Novartis AG said it will fold its specialized cell and gene therapies unit into other
Cell Therapy Breakthrough in Understanding How Stem Cells Become Specialized By Staff Reports 4 years ago Scientists at Sanford Burnham Prebys Medical Discovery Institute (SBP) have made a major advance in
Diabetes Joint Research Collaboration Aims to Advance Human Clinical Trials for the Treatment of Hypoglycemic Unawareness Patients with Severe Type 1 Diabetes By Staff Reports 4 years ago A new research funding agreement between the Juvenile Diabetes Research Foundation (JDRF) and Sernova, a